Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

Characterization of P55, a multidrug efflux pump in Mycobacterium bovis and Mycobacterium tuberculosis.

Silva PE, Bigi F, Santangelo MP, Romano MI, Martín C, Cataldi A, Aínsa JA.

Antimicrob Agents Chemother. 2001 Mar;45(3):800-4.

2.
3.

Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth.

Ramón-García S, Martín C, Thompson CJ, Aínsa JA.

Antimicrob Agents Chemother. 2009 Sep;53(9):3675-82. doi: 10.1128/AAC.00550-09. Epub 2009 Jun 29.

4.

Contribution of the Rv2333c efflux pump (the Stp protein) from Mycobacterium tuberculosis to intrinsic antibiotic resistance in Mycobacterium bovis BCG.

Ramón-García S, Martín C, De Rossi E, Aínsa JA.

J Antimicrob Chemother. 2007 Mar;59(3):544-7. Epub 2007 Jan 22.

PMID:
17242035
5.

Characterization of tetracycline resistance mediated by the efflux pump Tap from Mycobacterium fortuitum.

Ramón-García S, Martín C, Aínsa JA, De Rossi E.

J Antimicrob Chemother. 2006 Feb;57(2):252-9. Epub 2005 Dec 22.

PMID:
16373429
6.

Role of P27 -P55 operon from Mycobacterium tuberculosis in the resistance to toxic compounds.

Bianco MV, Blanco FC, Imperiale B, Forrellad MA, Rocha RV, Klepp LI, Cataldi AA, Morcillo N, Bigi F.

BMC Infect Dis. 2011 Jul 16;11:195. doi: 10.1186/1471-2334-11-195.

7.

Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis.

Danilchanka O, Mailaender C, Niederweis M.

Antimicrob Agents Chemother. 2008 Jul;52(7):2503-11. doi: 10.1128/AAC.00298-08. Epub 2008 May 5.

8.

Functional and genetic characterization of the tap efflux pump in Mycobacterium bovis BCG.

Ramón-García S, Mick V, Dainese E, Martín C, Thompson CJ, De Rossi E, Manganelli R, Aínsa JA.

Antimicrob Agents Chemother. 2012 Apr;56(4):2074-83. doi: 10.1128/AAC.05946-11. Epub 2012 Jan 9.

9.

Knockout mutation of p27-p55 operon severely reduces replication of Mycobacterium bovis in a macrophagic cell line and survival in a mouse model of infection.

Bianco MV, Blanco FC, Forrellad MA, Aguilar D, Campos E, Klepp LI, Hernández-Pando R, Cataldi AA, Bigi F.

Virulence. 2011 May-Jun;2(3):233-7. Epub 2011 May 1.

PMID:
21543883
10.

Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis.

Larsen MH, Vilchèze C, Kremer L, Besra GS, Parsons L, Salfinger M, Heifets L, Hazbon MH, Alland D, Sacchettini JC, Jacobs WR Jr.

Mol Microbiol. 2002 Oct;46(2):453-66.

12.

Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis.

Rodrigues L, Wagner D, Viveiros M, Sampaio D, Couto I, Vavra M, Kern WV, Amaral L.

J Antimicrob Chemother. 2008 May;61(5):1076-82. doi: 10.1093/jac/dkn070. Epub 2008 Feb 29.

PMID:
18310137
13.

Identification of mutations related to streptomycin resistance in clinical isolates of Mycobacterium tuberculosis and possible involvement of efflux mechanism.

Spies FS, da Silva PE, Ribeiro MO, Rossetti ML, Zaha A.

Antimicrob Agents Chemother. 2008 Aug;52(8):2947-9. doi: 10.1128/AAC.01570-07. Epub 2008 Jun 9.

14.

Association of the Rv0679c protein with lipids and carbohydrates in Mycobacterium tuberculosis/Mycobacterium bovis BCG.

Matsuba T, Suzuki Y, Tanaka Y.

Arch Microbiol. 2007 Apr;187(4):297-311. Epub 2007 Jan 25.

PMID:
17252234
15.

jefA (Rv2459), a drug efflux gene in Mycobacterium tuberculosis confers resistance to isoniazid & ethambutol.

Gupta AK, Reddy VP, Lavania M, Chauhan DS, Venkatesan K, Sharma VD, Tyagi AK, Katoch VM.

Indian J Med Res. 2010 Aug;132:176-88.

16.

Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis.

Piddock LJ, Williams KJ, Ricci V.

J Antimicrob Chemother. 2000 Feb;45(2):159-65.

PMID:
10660497
17.

MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212.

La Rosa V, Poce G, Canseco JO, Buroni S, Pasca MR, Biava M, Raju RM, Porretta GC, Alfonso S, Battilocchio C, Javid B, Sorrentino F, Ioerger TR, Sacchettini JC, Manetti F, Botta M, De Logu A, Rubin EJ, De Rossi E.

Antimicrob Agents Chemother. 2012 Jan;56(1):324-31. doi: 10.1128/AAC.05270-11. Epub 2011 Oct 24.

18.

Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5-MmpL5 efflux system.

Milano A, Pasca MR, Provvedi R, Lucarelli AP, Manina G, Ribeiro AL, Manganelli R, Riccardi G.

Tuberculosis (Edinb). 2009 Jan;89(1):84-90. doi: 10.1016/j.tube.2008.08.003. Epub 2008 Oct 11.

PMID:
18851927
19.

Role of mycobacterial efflux transporters in drug resistance: an unresolved question.

De Rossi E, Aínsa JA, Riccardi G.

FEMS Microbiol Rev. 2006 Jan;30(1):36-52. Review.

20.

Farnesol, a potential efflux pump inhibitor in Mycobacterium smegmatis.

Jin J, Zhang JY, Guo N, Sheng H, Li L, Liang JC, Wang XL, Li Y, Liu MY, Wu XP, Yu L.

Molecules. 2010 Oct 29;15(11):7750-62. doi: 10.3390/molecules15117750.

Supplemental Content

Support Center